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We describe the detection of specific, conserved DNA sequences of herpes simplex virus (HSV)
type 1 by means of a novel, high sensitivity acoustic biosensor. Repeated assays on planar and
polymeric carboxylic acid- and biotin-presenting surface chemistries enabled statistical
comparison of assay specificity and sensitivity and evaluation of assay Z-factor scores. Using a
three minute hybridisation with NeutrAvidin capture for signal enhancement, it was possible to
detect HSV viral nucleic acids at 5.2 6 10211 M concentration.
Introduction
Nucleic acid-based recognition of viral sequences provides a
precise and accurate method for clinical screening, diagnosis
and monitoring the efficacy of anti-viral therapy. Alternative
methods such as cell culture detection and enzyme-linked
immunosorbent assay (ELISA) are slow in comparison.1 Most
nucleic acid-based tests utilise PCR to amplify nucleic acids
and use fluorophore labels for detection. Real-time, label-free
biosensors have the potential to provide an alternative to the
current nucleic acid-based tests if the required sensitivity is
reached and the size of the biosensors is miniaturised.
Biosensors using quartz crystal microbalance (QCM)
technology provide a label-free method for detecting and
analysing molecules and, unlike more complex optical
biosensors, QCM devices have the prospect of miniaturisation.
Therefore QCM sensors provide an ideal platform for nucleic
acid-based recognition. The first nucleic acid detection using
QCM technology was performed by Fawcett et al.2 Fawcett
and colleagues immobilised single-stranded DNA probes on
the sensor and observed the hybridisation of the target as a
frequency decrease. Since this first example, several papers
have been published on nucleic acid detection using QCM
devices. For example Tombelli et al. developed a QCM
biosensor for a specific DNA sequence from methicillin-
resistant Staphylococcus aureus (MRSA)3 – a major cause of
hospital infections. They detected both synthetic nucleotides
and PCR products with a concentration of 3 6 1028 M PCR
products resulting in a 38 ¡ 3 Hz frequency change.
In the current study, we describe the detection of specific,
conserved DNA sequences of herpes simplex virus (HSV)
type 1. HSV causes recurrent mucosal infections of the eye,
mouth and genital tract. HSV type 1 establishes a lifelong
latent infection within the host which can subsequently
reactivate to cause recurrent infections and occasionally life-
threatening HSV encephalitis. Following infection the virus
gains access to sensory nerve terminals and latency is
established in corresponding sensory neurones.4 Two different
probe and complementary target sets were used for the HSV
recognition assays that are from ICP0 and VP16 gene regions
of the HSV viral sequence. ICP0 is one of the infected-cell
proteins (ICPs) that accumulate in infected cells but is absent
from uninfected cells. ICP0 activates genes introduced into
cells by transfection or infection.5 VP16 is an essential
structural protein and also functions as a major virion
transactivator of virus gene expression. VP16 interacts with
two cellular proteins, Oct-1 and HCF (host cell factor), and
this complex binds to TAATGARAT motifs to activate the
transcription of the viral immediate-early genes.6 HSV
regulatory proteins VP16 and ICP0 play key roles to stimulate
viral gene expression during the earliest stages of infection;7
thus, clinically it is relevant to diagnose HSV infection by
detecting the genes encoding VP16 or ICP0 since these are
important replication and virulence determinants.
In an earlier study, Napier et al. used an electrochemical
sensor to detect synthetic DNA and genomic DNA from HSV
type 2 after PCR amplification.8 In another study, Kara et al.
used an electrochemical sensor to detect and differentiate HSV
type 1 and type 2 viral sequences using both synthetic and
PCR amplified real samples.9 In the current study, a RAP¤id
instrument was used as the biosensor platform for the detec-
tion of HSV type 1 viral sequences. One notable advantage of
RAPTM (Resonant Acoustic ProfilingTM) detection over more
established optical label-free detection is the relative insensi-
tivity of acoustics to changes in solvent/medium when running
samples in complex media such as serum, plasma or whole
blood. Optical detection systems suffer from large bulk shifts
which need to be minimised by calibration routines and
dilution of the sample. In contrast, acoustic systems are not
affected by refractive index changes, but are instead sensitive
to bulk effects dominated by the viscosity and density of the
media.10 Thus viral detection from clinical samples with
minimal sample processing is feasible when acoustic sensors
are employed for nucleic acid testing. The RAP¤id system
possesses multi-channel sensors, a low-stress crystal mount,
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microfluidics, higher fundamental frequency sensors and
automated sample handling, which together enhance system
sensitivity and robustness.
The sensitivity of oligonucleotide hybridisation achieved
by QCM sensors has been previously reported to be ca.
1028 M.11–13 Nanoparticles are commonly used to enhance
the sensitivity of hybridisation to the region of 10215–
10216 M.14–16 In this paper we show that without the use of
nanoparticles but utilising capture protein, a hybridisation
sensitivity of 10211 M can be achieved.
For this study, we have compared three different surface
chemistries according to their hybridisation performances. The
optimised surface chemistry was then combined with a simple
signal amplification method to enhance the limit of detection
for HSV viral DNA recognition.
Experimental
RAP experiments were conducted using an automated four-
channel RAP¤id 4 instrument (RAP¤id 4; Akubio Ltd,
Cambridge, UK). The instrument applies the principles of
QCM, in that a high frequency (16.5 MHz) voltage is applied
to a piezoelectric quartz crystal to induce the crystal to
resonate, and its resonance frequency is then monitored in real
time. RAP¤id 4 integrates acoustic detection with a con-
tinuous flow microfluidic delivery system, a thermal control
unit, and automated sample handling. Four individual flow
cells enable up to four measurements to be performed
simultaneously. The volume of the flow cell used in this study
was 900 nl. The exchange rate in the flow cells could be set as
slow as 2 s at a flow rate of 25 ml min21 and as fast as 14 ms at
a flow rate of 4000 ml min21. To conserve sample, 25 ml min21
was employed for the pathfinder assay development. Baseline
drift observed during the study was 0.25 ¡ 0.15 Hz (n = 12)
after docking and priming the sensor chips. The operating
temperature was 25 ¡ 0.5 uC throughout the assays.
Sensor chip fabrication
AKT¤iv Covalent sensor chips were fabricated using a pro-
prietary protocol and carboxymethyldextran-T500 (CMD-
T500) polymer sensor chips were fabricated according to the
protocol described by Li et al.17
Fabrication of biotin chips was as follows, with all
operations carried out in a class 10 000 cleanroom. Gold-
coated 17 MHz quartz sensor chips were cleaned using a
proprietary plasma etching process in a PT7160 RF Plasma
Barrel etcher (Quorum Technologies, Newhaven, UK) for 55 s.
The cleaned quartz resonators were then submerged in an
aqueous solution of 0.5 mM biotin-PEG-disulfide (Polypure,
Oslo, Norway) overnight. After rinsing with water, the sensor
chips were dried and assembled into sensor cassettes. Biotin-
coated sensors were stored in the dark under nitrogen until
required.
Sensor surface preparation for AKT¤iv Covalent sensor chips
AKT¤iv Covalent sensor chips (Akubio Ltd, Cambridge, UK)
were employed for the assays. Sensor surfaces were prepared
by immobilising NeutrAvidin (NA; Perbio Science UK Ltd,
Cramlington, UK) on sensors using conventional amine
coupling chemistry. Running buffer used for immobilisation
was degassed Dulbecco’s modified phosphate buffered saline
(PBS, pH 7.4; Sigma-Aldrich, Poole, UK). The flow rate of the
buffer for the assay was 25 ml min21. Sensor surfaces were first
activated with a 1 : 1 mixture of 400 mM 1-ethyl-3-(3-
dimethylaminopropyl)-carbodiimide (EDC) and 100 mM
N-hydroxysuccinimide (NHS) (LINK¤it Coupling Solution
kit; Akubio Ltd, Cambridge, UK), prepared in 0.22 mm-
filtered deionised water, and mixed immediately prior to use
(final concentrations: 200 mM EDC and 50 mM NHS). EDC–
NHS was injected simultaneously across all four sensor
surfaces for 3 min. NA (50 mg ml21 in PBS buffer) was then
injected simultaneously across the sensor surfaces for 3 min.
Non-reacted NHS esters were capped with 1 M ethanolamine,
pH 8.5 (LINK¤it Coupling Solution kit; Akubio Ltd,
Cambridge, UK). The frequency changes were recorded
2 min after the protein injection was completed. After NA
immobilisation, the running buffer was changed to Tris buffer
comprising 20 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA,
pH 7. The biotinylated complementary surface probe and
scrambled surface probe (biotinylated probes; TIB Molbiol,
Berlin, Germany) were diluted in Tris buffer to 10 mg ml21 and
injected separately over different flow cells for 3 min to create
active and control surfaces. The frequency changes of the
biotinylated probes captured were recorded 4 min after the end
of the injection.
Sensor surface preparation for CMD-T500 polymer sensor chips
The protocol used for DNA capture and hybridisation on
CMD-T500 polymer sensor chips was the same as for AKT¤iv
Covalent sensor chips, except that immobilisation of NA was
performed using 10 mM phosphate buffer pH 6.5 instead of
PBS buffer pH 7.4.
Sensor surface preparation for biotin sensor chips
Running buffer used for immobilisation was PBS and the flow
rate was 25 ml min21. NA was prepared for immobilisation at
50 mg ml21 in PBS, and injected simultaneously across separate
sensor surfaces of the biotin chips for 3 min. A solution of
0.1 M HCl was then injected for 1 min to remove the loosely
bound excess protein from the surface. The immobilisation
level was recorded 1 min after HCl injection as a frequency
change. After NA capture on the biotin surface, running buffer
was changed to Tris buffer (20 mM Tris-HCl, 150 mM NaCl,
1 mM EDTA, pH 7). The biotinylated complementary surface
probe and scrambled surface probe (biotinylated probes; TIB
Molbiol, Berlin, Germany) (Table 1) were diluted in Tris
buffer to 10 mg ml21 and each injected over separate flow cells
for 5 min to create active and control surfaces. The level of
surface probe capture was recorded 4 min after the end of the
injection as a frequency change.
Hybridisation assay
Synthetic target ssDNA oligomers (ssDNA; TIB Molbiol,
Berlin, Germany) were prepared in Tris buffer (20 mM
Tris-HCl, 150 mM NaCl, 1 mM EDTA, pH 7) (Table 1).
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Single-stranded target DNA at specified concentrations was
injected over biotinylated probe-captured AKT¤iv Covalent
chips for 3 min to allow hybridisation. After a dissociation
period under Tris buffer flow at 25 ml min21, surfaces were
regenerated by two successive 30 s injections of 1 mM HCl.
Frequency change due to hybridisation was recorded 180 s
after the injection started.
Signal enhancement assay
The running buffer used for the assay was Tris buffer
comprising 20 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA,
0.05% Tween 20, pH 7. A sample of 10 mM biotin (biotin;
Sigma-Aldrich, Poole, UK) in Tris buffer was injected for
1 min to block the remaining active sites of the NA layer. The
VP16 target sequence was injected to the probe-immobilised
sensor surface and allowed to hybridise for 3 min. Then VP16
detection probe at 0.5 or 2.5 mg ml21 concentrations was
injected to allow hybridisation with the VP16 target sequence
for 3 min. Finally 5 mg ml21 NA was injected to the resultant
sensor surface to be captured by the VP16 detection probe
for 3 min (Fig. 1). The frequency change due to oligomer
hybridisation and NA capture were recorded 180 s after the
injection started.
Results and discussion
The RAP¤id 4 biosensor was used as the platform for the HSV
type 1 nucleic acid tests. In order to select the most suitable
sensor chip for nucleotide-based detection, three types of
sensor chips – AKT¤iv Covalent, biotin, and CMD-T500
polymer chips – were compared. Reproducibility, signal-to-
noise ratio, assay quality, percentage activity and limit of
detection were investigated and compared for these three
sensor chip types. After sensor chip selection, to reduce the
limit of detection, a simple approach was applied by using NA
as a secondary capture protein.
HSV-ICP0 hybridisation assay
The ICP0 surface probe was captured onto the active flow cells
of NA-immobilised AKT¤iv Covalent-, Biotin- and CMD-
T500 polymer-sensor chips. The ICP0 scrambled surface probe
was immobilised on separate flow cells as the control surfaces.
Biotinylated 28-mer surface probe captured on NA-immobi-
lised AKT¤iv Covalent chips produced an average frequency
change of 116¡ 6 Hz; on the biotin chips the result was 27¡
6 Hz; and on the CMD-T500 polymer chips 311 ¡ 51 Hz
(n = 6 for all sensor chips).
The specificity of the interaction was tested by employing a
non-complementary probe on the sensor surface; the hybridi-
sation signals resulting from these non-specific interactions
were not more than 4 Hz (data not shown) for the AKT¤iv
Covalent and biotin chips, and not more than 1 Hz (data not
shown) for the CMD-T500 polymer chip. These results showed
that the hybridisation on the sensor surfaces was specific and
that the signal-to-noise ratio for CMD-T500 polymer chips
was higher than the other sensor chips (Table 2). The non-
specific response to the non-complementary sequence was
subtracted from each hybridisation response by using Akubio
Workbench Software.
The calibration curve obtained with complementary oligo-
nucleotides for the ICP0 surface probe in a concentration
range between 0.3 and 40 mg ml21 is shown in Fig. 2. The
hybridisation responses were superimposed and aligned to the
start of the sample injection and then fitted to a global 1 : 1
Table 1 Nomenclatures and sequences of HSV type 1 and control oligonucleotides
Name DNA sequence
ICP0 surface probe 59-Biotin-TCG CAT TTG CAC CTC GGC ACT CGG AGC G-39
ICP0 scrambled surface probe 59-Biotin-CCA TCG GCA TGT ACC GTA TCG GCG CGT C-39
ICP0 target sequence 59-CGC TCC GAG TGC CGA GGT GCA AAT-39
VP16 surface probe 59-Biotin-CTC GTT GGC GCG CTG AAG CAG GTT TTT G-39
VP16 scrambled surface probe 59-Biotin-ACC TGG GCA TGT ATG GTG TCG TCG CGT T-39
VP16 target sequence 59-AAA ACT TCC GTA CCC CTC AAA AAC CTG CTT CA-39
VP16 detection probe 59-GGG TAC GGA AGT TTT TCA CTC GAC-Biotin-39
Fig. 1 Schematic of the assay format for hybridisation signal
enhancement by the capture of NA to the detection probe.
Table 2 Summary of the results for HSV-ICP0 hybridisation using different sensor chips
Sensor chip type KD/mM 2dFmax/Hz Signal/noise
a Surface activity (%)a Z-Factora
Biotin 0.021 ¡ 0.011 21 ¡ 6 6 73 0.65
AKT¤iv Covalent 0.018 ¡ 0.008 69 ¡ 14 20 61 0.89
CMD-T500 polymer 0.024 ¡ 0.004 118 ¡ 20 140 48 0.56
a Results were calculated using ICP0 hybridisation data for 40 mg ml21 target sequence (n = 6).
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Langmuir binding model, giving a KD of ca. 0.021 mM for the
CMD-T500 polymer, biotin and AKT¤iv Covalent chips
(Table 2). Although the DNA capture and hybridisation res-
ponse intensities varied among sensor chips, the KD values of
oligonucleotide hybridisation were very similar to each other,
indicating a good inter-assay consistency even with variant
surface chemistry. The detection limit for target hybridisation
was found to be ca. 9 6 1028 M for all sensor chips.
Z-Factor analysis was employed to assess the quality of the
assays using the different sensor chip types. The Z-factor18
provides an easy and useful measure for assay quality and has
been a widely accepted standard. The Z-factor reflects both the
assay signal dynamic range and the data variation associated
with the signal measurements: a Z-factor between 0.5 and 1.0
indicates an excellent assay; between 0 and 0.5 is marginal; and
less than 0 means that the signals from the positive and
negative controls overlap, indicating the invalidity of the assay
results [eqn (1); average (m) and standard deviation (s) of both
active and control DNA hybridisation results].
Z-factor~1{
3| sazscð Þ
mazmcj j
(1)
Z-Factor values were calculated for the hybridisation of
40 mg ml21 ICP0 target sequence. The Z-factor values
were above 0.5 for all sensor types indicating excellent
assay performances; however, AKT¤iv Covalent chips with a
Z-factor of 0.89 performed better than the other sensor chip
types (Table 2).
The percent activities of the sensor chips were calculated
from the ratio of the experimentally determined DNA
hybridisation response with the theoretical maximum DNA
hybridisation response. The activity for DNA hybridisation
was higher for biotin chips (73%) than the other sensor chips,
although the absolute magnitude of the hybridisation signal
was lower (Table 2). This indicates potentially that whilst the
biotin chip presents fewer binding sites to the solution phase
for DNA capture, those sites present are better able to effect
subsequent DNA hybridisation from solution.
Initial rate analysis is a useful tool to determine the
concentration of unknown samples. The initial rates of
hybridisation obtained from linear regression were concentra-
tion-dependent, and plots of initial rate against DNA
concentration yielded a straight line that passed near the
origin (Fig. 3). The standard deviations of the initial rate
results for CMD-T500 polymer chips were much higher than
the other sensor types; this would prevent accurate measure-
ment of the concentration of unknown samples when using
CMD-T500 polymer chips. Both AKT¤iv Covalent and biotin
sensor chips showed very low standard deviations and a linear
regression line with an R2 value of 0.99. The dynamic range of
the initial rate correlation with DNA concentration was higher
for AKT¤iv Covalent sensors than the biotin sensor chips.
In summary, all three sensor types – AKT¤iv Covalent,
CMD-T500 polymer and biotin chips – possessed a very
similar limit of detection for ssDNA (9 6 1028 M) and gave
similar KD values for hybridisation (ca. 0.021 mM). The signal-
to-noise ratio, Z-factor, percentage activity and initial rate
values were calculated and compared for all sensor types.
CMD-T500 polymer chips possessed a high signal-to-noise
ratio; however, surface activity and Z-factor results were not
as good as AKT¤iv Covalent sensor chips. In addition, the
CMD-T500 assays possessed higher inter-assay variability.
Although the activity of biotin chips was higher than the
others, biotin chips had a very low signal-to-noise ratio and a
smaller dynamic range with respect to the other sensor chip
types. As such, both CMD-T500 and biotin chips were
excluded from further optimisation studies, and AKT¤iv
Covalent sensor chips were selected as the most suitable
candidate for DNA hybridisation assays due to the higher
assay quality dynamic range and reproducibility.
HSV-VP16 hybridisation and signal enhancement assay
50 mg ml21 NA was immobilised to AKT¤iv Covalent sensors,
then 10 mg ml21 biotinylated probe was captured on all
sensor surfaces. Biotinylated DNA capture on the NA layer
resulted in a 243 ¡ 14 Hz response (n = 16, data not shown),
followed by capping of the remaining NA active sites with
10 mM biotin.
Two types of control assays were run to determine the
non-specific binding of NA to the VP16 scrambled probe and
to the VP16 surface probe. The VP16 scrambled sequences
Fig. 2 Frequency changes after 3 min of hybridisation of the ICP0
target sequence to the surface probe (n = 6). ($) CMD-T500 polymer
chip, (e) AKT¤iv Covalent chip, (%) biotin chip.
Fig. 3 Initial rate results for ICP0 hybridisation (n = 6). ($) CMD-
T500 polymer chip, (e) AKT¤iv Covalent chip, (%) biotin chip.
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were captured onto the NA layer and this was followed
by sequential injections of 1 mg ml21 VP16 target sequence,
1 mg ml21 VP16 detection probe and 5 mg ml21 NA. The
resulting non-specific binding of NA was 9 Hz (data not
shown). As a second control, the VP16 surface probe was
captured onto the sensor surface and then 5 mg ml21 NA was
injected. Non-specific binding of NA to the VP16 surface
probe resulted in a 7¡ 1 Hz (n = 3) frequency change (Fig. 4).
The hybridisation between the VP16 surface probe and the
complementary oligonucleotide VP16 target sequence was
tested in a concentration range varying from 5.2 6 10211 to
1.3 6 1027 M (Fig. 5). Whilst 5 and 10 ng ml21 VP16 target
sequence hybridisation to the VP16 surface probe did not
result in any frequency response from VP16 detection probe
hybridisation, subsequent NA capture on these surfaces
resulted in 9 ¡ 3 and 17 ¡ 4 Hz responses respectively. The
resultant theoretical detection limit of DNA hybridisation
for this assay with NA signal amplification was 1 ng ml21
(1 6 10210 M). Notably, we have found in the course of this
work that DNA hybridisation efficiency can be higher when
hybridisation is performed at the annealing temperature in free
solution rather than via in situ hybridisation to a probe on the
biosensor surface. Hence, the first target sequence and
detection probe were hybridised at 55 uC in a tube in free
solution, then injected over the biosensor surface. Subsequent
addition of NA resulted in a 5 ¡ 2 Hz frequency change for
5.2 6 10211 M target concentration (Fig. 5). The same
concentration of target sequence did not result in any response
when hybridisation was performed on the sensor surface. In
conclusion, the detection limit for VP16 target sequence
hybridisation was 5.2 6 10211 M when NA was used for
signal enhancement and hybridisation performed at the
annealing temperature.
Conclusion
Nucleic acid-based testing has been increasingly used for the
detection of viral pathogens. The implementation of biosensors
to nucleic acid-based recognition can provide real-time, label-
free and quick testing of samples. Current optical label-free
biosensors are large and their detection limits require
significant improvement, especially in complex media typical
of clinical matrices. Piezoelectric biosensors are able to operate
in un-diluted, un-processed complex media10 and, being
entirely electronic, are suitable for miniaturisation. A pre-
liminary study was conducted for the detection of viral
sequences using a piezoelectric biosensor, the RAP¤id instru-
ment. The hybridisation performance of three different sensor
chips including AKT¤iv Covalent chips, biotin chips and
CMD-T500 polymer chips were compared and AKT¤iv
Covalent chips were found to be the most suitable candidates
for further studies – due to their hybridisation capacity, high
reproducibility and higher dynamic range. After a hybridisa-
tion time of only three minutes and NA capture as a signal
enhancer, it was possible to detect HSV viral nucleic acids
at 5.2 6 10211 M concentration. This level of sensitivity
necessitates amplification of DNA by means of PCR or
PCR-like amplification methods; however, by reducing the
detection limit of the DNA to the region of 10218 M or lower,
it may be possible to avoid PCR amplification. Further studies
will continue to improve the limit of detection for the
recognition of HSV type 1 and other viral nucleic acids.
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